Trial Profile
Prospective, single centre, open label trial to study efficacy and safety of insulin degludec in frail elderly patients with type-2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 15 Mar 2016 New trial record